findmyKOL
Clinical trialNCT06239155Active, not recruitingPhase 1/PHASE2Interventional

A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors

SponsorAscentawits Pharmaceuticals, LtdEnrollment51Advanced Solid TumorsHepatocellular Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Guangdong Qifu Hospital

    Guangzhou, Guangdong, China

  • Henan Cancer Hospital

    Zhengzhou, Henan, China

  • Chinese People'S Liberation Army Eastern Theater General Hospital Qinhuai Medical District

    Nanjing, Jiangsu, China

  • the First Affiliated Hospital of China Medical University

    Shenyang, Liaoning, China

  • Shanghai East Hospital

    Shanghai, Shanghai Municipality, China

  • Sir Run Run Shaw Hospital (srrsh), Affiliated With the Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Sept 2019
Primary completion
30 Nov 2025
Completion
30 Nov 2025
Last update posted
25 Feb 2025
Registered enrollment
51
Registry id
NCT06239155

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.